Aurora Maintains Shareholder Recommendation to Take No Action at this Time as Curaleaf Has Yet to File Their Revised Hostile Bid
Key Highlights
- ➤Curaleaf yet to file formal revised bid for Aurora (ACB).
- ➤Revised offer implies US$5.00 per Aurora share, including US$1.00 cash.
- ➤Curaleaf will provide pro forma financials for the combined company.
- ➤Bid expiry extended to 11:59pm Mountain Time on December 4, 2026.
- ➤Aurora shareholders advised to take no action pending Board recommendation.
Expert Statements
Miguel Martin, Executive Chairman and CEO of Aurora Cannabis
“Today's announcement by Curaleaf is not a formal revised bid, and Aurora has not yet received the materials required to conduct a full and proper evaluation. While the announcement suggests an intention to address concerns Aurora identified with Curaleaf's initial Hostile Bid, the Special Committee of independent directors will review any formal revised offer once received with the same rigorous, independent and disciplined process applied previously. The Committee's focus remains on determining what is in the best interests of Aurora and Aurora shareholders, and the Board will communicate its recommendation once that review is complete.”
Aurora Maintains Shareholder Recommendation to Take No Action at this Time as Curaleaf Has Yet to File Their Revised Hostile Bid PR Newswire
* Curaleaf has yet to file a Notice of Variation and Change to revise its offer. Once filed, the Special Committee will complete a thorough and comprehensive review prior to issuing a formal recommendation to shareholders * Aurora's application to the Alberta Securities Commission delivered results for shareholders: Curaleaf's latest update indicates that Aurora shareholders will be provided with pro forma financials and a bid timeline that complies with securities laws * Questions about the Hostile Bid or would like to stay informed? Please contact Kingsdale Advisors toll-free at 1-800-749-9052 within North America, call or text 416-623-4172 or at contactus@kingsdaleadvisors.com (mailto:contactus@kingsdaleadvisors.com) . EDMONTON, AB, Oct. 5, 2026 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NASDAQ: ACB), the Canadian-based leading global medical cannabis company, responded today to a press release issued by Curaleaf Holdings, Inc. ("Curaleaf") regarding its stated intention to file a Notice of Variation and Change to revise its hostile take-over bid (the "Hostile Bid") for all of the issued and outstanding common shares of the Company (the "Aurora Shares") to offer revised implied consideration of US$5.00 per Share, consisting of 0.4013 subordinate voting shares of Curaleaf plus US$1.00 in cash per Aurora Share.
Get started
Create a free account to read the full story.